Grant of Award
Chief Operating Officer granted nil-cost share options over 94,156 ordinary shares under LTIP 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK – 02 October 2026: OXB (LSE: OXB) (the "Company"), a quality and innovation-led cell and gene therapy CDMO, announces that on 30 September 2026, nil-cost share options over ordinary shares of 50 pence each in the Company were granted under the Company’s 2024 Long Term Incentive Plan ("LTIP") as follows:
| Type | Name of individual | Title | Number of share options granted |
|---|---|---|---|
| LTIP - Grant in respect of 2026 | Eric Schmidhaeuser | Chief Operating Officer | 94,156 |
LTIP - Grant in respect of 2026: The 2026 LTIP metrics are 60% revenue, 40% Operating EBITDA margin, with target ranges in each case assessed on a constant currency basis which is set out in the Company’s Directors’ Remuneration Report for 2025.
| 1. | Details of the Issuer or emission allowance market participant | |
| a) | Full name of the entity | Oxford Biomedica plc |
| b) | LEI code | 213800S1GVQNXQ15K851 |
| 2. | Reason for the notification | |
| a) | Position/status | Chief Operating Officer |
| b) | Initial notification / amendment | Initial Notification |
| 3. | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Is this a PDMR or PCA Submission | Submission for PDMR |
| b) | Name of natural person | Eric Schmidhaeuser |
| a) | Date of the transaction | 2026-09-30 |
| b) | Description of instrument | Share |
| c) | Identification code | ISIN: GB00BDFBVT43 |
| d) | Place of the transaction | Outside the trading venue |
| e) | Currency | GBP – British Pound |
| f) | Nature of the transaction | Grant of LTIP awards over Ordinary Shares under the Company's Long Term Incentive Plan. No consideration was paid for the grant of the awards. |
| g) | Price(s) and volumes(s) | Award Price Volume LTIP grant in respect of 2026 Nil 94,156 |
| h) | Aggregated information | |
| - Aggregated volume | LTIP awards granted over 94,156 shares in total | |
| - Price | Nil |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.